Clinical Trials Browser

Phase 2 × cc-486 × Gynecologic × Clear all

NCT02900560 2022-06-10

Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer

Phase 2 Terminated

34 enrolled 15 charts

Carcinoma, Ovarian Epithelial

NCT02811497 2021-04-01

METADUR

Phase 2 Completed

BreastGastrointestinalGynecologic

Microsatellite Stable Colorectal Carcinoma